FOR IMMEDIATE RELEASE
Efferent Labs™ at 2018 BIO International Convention
(BUFFALO, NY) April 15, 2018 – Efferent Labs CEO Bill Rader will present at the 2018 BIO
International Convention in Boston, MA on June 4, 2018. Mr. Rader will discuss
Efferent’s Living Biosensor System and its innovative technology and updates on
research and development efforts. In addition, Mr. Rader will address the value of
CytoComm™ as a platform technology with multiple applications including preclinical
R&D, clinical testing, oncology, cardiology, and metabolic monitoring.
Efferent Labs™ will also participate in the 2018 BIO Exhibition (booth 343), the world’s
largest biotechnology gathering featuring more than 1,700 exhibitors.
More information about Efferent Labs™ can be found at www.efferentlabs.com
ABOUT EFFERENT LABS™:
Efferent Labs™ is a developer of high value medical diagnostic technology. Efferent Labs’
proprietary technology, the CytoComm™ Living Cell Biosensor System, is a platform
used for in vivo, real-time monitoring of biological signaling and cellular response. The
company is based in Buffalo, NY and is a 2014 43North award winner and 2015 Verizon
Powerful Answers semi-finalist. FOR MORE INFORMATION CONTACT:
press@efferentlabs.com
ABOUT 2016 BIO INTERNATIONAL CONVENTION:
The BIO International Convention, hosted by the Biotechnology Industry Organization
(BIO), represents more than 1,100 biotechnology companies, academic institutions,
state biotechnology centers and related organizations across the United States and in
more than 30 other nations. BIO members are involved in the research and
development of innovative healthcare, agricultural, industrial and environmental
biotechnology products.
BIO performs many services for members, but none of them are more visible than the
BIO International Convention. The BIO International Convention helps BIO fulfill its
mission to help grow the global biotech industry.
###
